Abstract
Exogenous administration of 5-aminolevulinic acid (ALA) is becoming widely used to enhance the endogenous synthesis of Protoporphyrin IX (PpIX) in photodynamic therapy. We analysed porphyrin formation in chemically induced squamous papillomas, after topical application of ALA and ALA hexyl ester (He-ALA) administered in different formulations, as well as the pattern of distribution in the internal organs, and the synthesis of porphyrins in distant tumoural and normal skins. A lotion formulation containing DMSO and ethanol was the best vehicle for topical ALA delivery to papillomas, whereas cream was the most efficient formulation for He-ALA application. Similar porphyrin concentration can be accumulated in the skin tumours employing either ALA or He-ALA delivered in their optimal formulations. The use of cream as a vehicle of both ALA and He-ALA, induces highest porphyrin tumour/normal skin ratios. The main advantage of using He-ALA is that porphyrins synthesized from the ester are more confined to the site of application, thus inducing low porphyrin levels in normal skin, liver, blood and spleen, as well as in papillomas distant from the point of application, independently on the vehicle employed, so reducing potential side effects of photodynamic therapy. © 2001 Cancer Research Campaign http://www.bjcancer.com
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Boehncke W, Sterry W and Kaufmann R (1994) Treatment of psoriasis by topical photodynamic therapy with polychromatic light. Lancet 343: 801
Burns F, Albert R, Altshuler B and Morris E (1983) Approach to risk assessment for genotoxic carcinogens based on data from the mouse skin initiation-promotion model. Environ Health Perspect 50: 309–320
Casas A, Fukuda H and Batlle A (1999a) Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles. Br J Cancer 81: 13–18
Casas A, Batlle A, Butler A, Robertson D, Brown E, MacRobert A and Riley P (1999b) Comparative effect of ALA derivatives on Protoporphyrin IX production in human and rat skin organ cultures. Br J Cancer 80: 1525–1532
Casas A, Fukuda H, Di Venosa G and Batlle A (2000a) The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolevulinic acid. Implications in cutaneous photodynamic sensitization. Br J Dermatol 143: 564–572
Casas A, DiVenosa G, Casentini C, Meiss R, Vanzulli S, Fukuda H and Batlle A (2000b) Terapia fotodinámica en el tratamiento de tumores de piel inducidos quámicamente. Rev Argent Dermatol 81: 144–152
Casas A, Fukuda H, Di Venosa G and Batlle A (2001) Photosensitisation and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer, (In press)
Dougherty T (1984) Photodynamic therapy (PDT) of malignant tumors. Crit Rev Oncol Hematol 2: 83–116
Fritsch C, Lang K, Neuse W, Ruzicka T and Lehmann P (1998) Photodynamic diagnosis and therapy in dermatology. Skin Pharmacol Appl Skin Physiol 11: 358–373
Fukuda H, Paredes S and Batlle A (1992) Tumor-localizing properties of porphyrins. In vivo studies using free and liposome encapsulated aminolevulinic acid. Comp Biochem Physiol 102B: 433–436
Gaullier J, Berg C, Peng Q, Anholt H, Selbo P, Ma L and Moan J (1997) Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 57: 1481–1486
Kennedy J and Pottier R (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6: 143–148
Kloek J and Beijersbergen van Henegouwen G (1996) Prodrugs for 5-Aminolevulinic acid for Photodynamic therapy. Photochem Photobiol 64: 994–1000
Kloek J, Akkermans W and Beijersbergen van Henegouwen G (1998) Derivatives of 5-Aminolevulinic acid for Photodynamic therapy: enzymatic conversion into protoporphyrin. Photochem Photobiol 67: 150–154
Kurwa H and Barlow R (1999) The role of photodynamic therapy in dermatology. Clin Exp Dermatol 24: 143–148
Peng Q, Warloe T, Moan J, Heyerdahl H, Steen H, Giercksky K and Nestland J (1995) Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem Photobiol 62: 906–913
Peng Q, Moan J, Warloe T, Iani V, Steen H, Bjørseth A and Nesland J (1996) Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B 34: 95–96
Rougier A and Lotte C (1986) Correlations between horny layer concentration and percutaneous absorption. In: Pharmacology and skin: 1. Skin Pharmacokinetics, Shroot & Schaeger: Switzerland
UK-Coordinating Committee on Cancer Research (1988) UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia (London, UKCCCR).
Van den Akker J, de Brujin H, Beijersbergen van Henegouwen G, Star W and Sterenborg H (2000a) Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer. Photochem Photobiol 72: 399–406
Van den Akker J, Iani V, Star W, Sterenborg H and Moan J (2000b) Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic to normal nude mouse skin: differences in Protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 72: 681–689
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Casas, A., Perotti, C., Fukuda, H. et al. ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitization. Br J Cancer 85, 1794–1800 (2001). https://doi.org/10.1054/bjoc.2001.2156
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2001.2156
Keywords
This article is cited by
-
Porphyrin Formation in Actinic Keratosis and Basal Cell Carcinoma after Topical Application of Methyl 5-Aminolevulinate
Journal of Investigative Dermatology (2006)
-
In Vitro Metabolism of 5-ALA Esters Derivatives in Hairless Mice Skin Homogenate and in Vivo PpIX Accumulation Studies
Pharmaceutical Research (2004)
-
Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: tissue distribution
British Journal of Cancer (2003)
